Why Smith & Nephew is an Attractive Takeover Target (Investment U)
Smith & Nephew Shares Advance After Takeover Speculation (BusinessWeek)
Smith & Nephew Rumors Continue to Swirl (Memphis Daily News)
The zombie deal that won't die: Smith & Nephew (MassDevice)
UK medical device maker Smith & Nephew ADR (NYSE: SNN) is over 150 years old. A leader in orthopedics, endoscopy and wound care, it makes an attractive takeover target.
The medical device industry is a great place to exploit rising longevity and living standards worldwide. But the global economic downturn...
